Estrella Immunopharma, Inc. Common Stock
ESLAEstrella Immunopharma, Inc. (ESLA) is a biotechnology company focused on developing innovative therapies aimed at immune modulation and autoimmune diseases. The company leverages advanced immunological research to create treatments intended to improve patient outcomes in various immune-related conditions.
Company News
Abbott Cooper PLLC has announced investigations into potential fiduciary duty violations and wrongdoing by the boards of directors of three companies: Abundia Global Impact Group, Inc. (formerly Houston American Energy Corp.), Estrella Immunopharma, Inc., and Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.). The law fir...
Abbott Cooper PLLC is investigating potential fiduciary duty violations and wrongdoing by Estrella Immunopharma's board of directors. The law firm is seeking stockholders to join the investigation on a contingency fee basis.
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ: ROI) shares rose 51.3% to $0.2250 in p...
